Flavia Linguanti

Arezzo, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort.

Imaging Modality and Outcomes of Metastasis-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer: An Updated Analysis of the PRECISE-MDT Cohort.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: November 16, 2025

Current and future trends of [18F]FDG PET/CT in pediatric Hodgkin lymphoma.

Current and future trends of [18F]FDG PET/CT in pediatric Hodgkin lymphoma.

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Published: October 28, 2025

Diagnostic Yield of [18F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients.

Diagnostic Yield of [18F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 22, 2025

Digital versus analogue PET in parathyroid imaging: comparison of PET metrics and machine learning-based characterisation of hyperfunctioning lesions (the DIGI-PET study).

Digital versus analogue PET in parathyroid imaging: comparison of PET metrics and machine learning-based characterisation of hyperfunctioning lesions (the DIGI-PET study).

Journal: European journal of nuclear medicine and molecular imaging

Published: June 19, 2025

Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study.

Impact of Metastasis-directed Therapy Guided by Different PET/CT Radiotracers on Distant and Local Disease Control in Oligorecurrent Hormone-sensitive Prostate Cancer: A Secondary Analysis of the PRECISE-MDT Study.

Journal: Radiology. Imaging cancer

Published: May 16, 2025

FDG-PET/CT Imaging in Chimeric Antigen Receptor-Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence.

FDG-PET/CT Imaging in Chimeric Antigen Receptor-Engineered T-Cell Treatment in Patients with B-Cell Lymphoma: Current Evidence.

Journal: PET clinics

Published: July 05, 2024

Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?

Biology-guided radiotherapy in metastatic prostate cancer: time to push the envelope?

Journal: Frontiers in oncology

Published: June 26, 2024

Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study).

Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study).

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: February 09, 2024

FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature.

FAPi-Based Agents in Thyroid Cancer: A New Step towards Diagnosis and Therapy? A Systematic Review of the Literature.

Journal: Cancers

Published: January 22, 2024

ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications.

ImmunoPET Targeting Receptor Tyrosine Kinase: Clinical Applications.

Journal: Cancers

Published: November 27, 2023

Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.

Texture analysis of 18F-FDG PET/CT and CECT: Prediction of refractoriness of Hodgkin lymphoma with mediastinal bulk involvement.

Journal: Hematological oncology

Published: September 26, 2023

Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors.

Clinical Application of ImmunoPET Targeting Checkpoint Inhibitors.

Journal: Cancers

Published: August 24, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026